The Role of Standardized Training in the Diagnosis of Interstitial Lung Disease by Transbronchial Lung Cryobiopsy

Launched by CHINA-JAPAN FRIENDSHIP HOSPITAL · Jan 30, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring how standardized training can improve the skills of doctors performing a procedure called transbronchial lung cryobiopsy (TBLC), which helps diagnose a condition known as interstitial lung disease (ILD). The study aims to see if this training helps doctors become more effective in using TBLC to gather lung tissue samples, which can lead to better diagnosis and treatment for patients with suspected ILD.

To be eligible for this trial, participants must be at least 18 years old and have suspected ILD, among other health criteria. This includes having a specific lung function test result and recent heart tests. Participants will receive training and take part in the TBLC procedure, allowing researchers to evaluate how the training impacts the learning and performance of the doctors involved. If you or a loved one meets the criteria and are interested, this study could contribute to improving lung disease diagnosis while helping healthcare professionals enhance their skills.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥18 years
• • suspected ILD.
• • ≤3 months since HRCT
• • Forced vital capacity (FVC) ≥50% of predicted value
• • Diffused lung carbon monoxide (DLCO) ≥35% predicted value
• • Echocardiography ≤ 12 months
• • Estimated pulmonary artery systolic pressure ≤40 mmHg
• • Body mass index (BMI) ≤35 kg/m2
• • Patient consent for experimentation
• Exclusion Criteria:
• • Patients with platelet counts less than 50 × 109/L or prothrombin time international normalized ratio (INR) higher than 1.5
• • Patients refused to participate in the experiment